The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC).
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - GRAIL; Lilly; Novartis
 
Jennifer A. Petersen
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Emma Clark
Employment - Roche
Patents, Royalties, Other Intellectual Property - Genentech/Roche
 
Claire Barton
Employment - Barton Oncology
Leadership - Shanghai Biomedical Co Ltd
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - CellCentric; Certara Inc; Macrophage Pharma; Mosaic Biomedicals; Norgine; Orion Clinical; Pique; Roche; T3 Pharmaceuticals
Other Relationship - Cancer Research UK; PTEN Foundation; Wellcome Trust
 
Eleonora Restuccia
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Marion Jennifer Procter
Research Funding - Roche (Inst)
 
Amir Sonnenblick
No Relationships to Disclose
 
Debora Fumagalli
Research Funding - AstraZeneca; Genentech (Inst); Novartis (Inst); Pfizer; Roche (Inst)
 
Damian Parlier
No Relationships to Disclose
 
Amal Arahmani
Research Funding - AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Giuseppe Viale
Honoraria - MSD Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dako; Roche/Genentech
Research Funding - Roche/Genentech; Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Celgene; Roche
 
Linda L. Reaby
No Relationships to Disclose
 
Elizabeth Frank
No Relationships to Disclose
 
Richard D. Gelber
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Periphagen; Pfizer; PharmaMar; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - Radius Health
 
Jose Bines
Honoraria - Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Roche
 
Gunter von Minckwitz
Stock and Other Ownership Interests - CARA GmbH
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Myriad Genetics (Inst); Pfizer (Inst); Roche (Inst); Vifor Pharma (Inst)
 
Sabina McGarrahan Gasper
Employment - Genentech/Roche
Stock and Other Ownership Interests - Pfizer